Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 14.62%

August 13, 2024
REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast as predicted by QuantWave's automated forecasting platform. The forecast signal date was on June 11, 2024, with the price at the time of signal standing at 1007.75 $. The direction predicted was long, and on August 13, 2024, the target price of 1155.14 $ was reached, resulting in a profit of 14.62%.

This achievement showcases the accuracy and reliability of QuantWave's analytics in forecasting stock movements. Several factors could have contributed to the stock's upward trajectory, including positive clinical trial results, regulatory approvals, or strong financial performance.

QuantWave provides a valuable resource for investors looking to capitalize on precise market predictions. Users can access forecasts for a wide range of stocks, presenting opportunities for potential profits. For those seeking to deepen their understanding of the investment strategy behind QuantWave, exploring QuantSchool's educational resources is recommended. QuantSchool offers a comprehensive professional investment framework that reveals key principles for generating consistent income using the QuantWave forecasting system.

Find out how the REGENERON PHARMACEUTICALS, INC. rate is expected to change

Get Forecast for REGN
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for REGN

REGNMay 9, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit Margin: A Victory for QuantWave  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit margin of 25.34%....

REGNMay 9, 2025QuantWave Forecast Achieves 24.9% Profit Target for Regeneron Pharmaceuticals, Inc. Stock  ~1 min.

Regeneron Pharmaceuticals, Inc. stock recently saw the successful achievement of a price target forecast as predicted by QuantWave's automated forecasting platform....

REGNMay 9, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Forecast Price Target with a Profit of 24.47%  ~1 min.

On February 28, 2025, QuantWave's forecasting system signaled a short position for REGENERON PHARMACEUTICALS, INC. stock when the price was at 697.71 $....

REGNApril 12, 2025Regeneron Pharmaceuticals Receives Dupixent Approval in Japan  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) has recently received approval for its drug Dupixent in Japan....

REGNApril 10, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 17.79%....



Related news

REGNAugust 19, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.57% Profit Margin  ~1 min.

On July 2nd, 2024, QuantWave issued a forecast signal for REGENERON PHARMACEUTICALS, INC., predicting a long position when the stock was trading at 1041.78 $....

REGNMay 9, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 25.34% Profit Margin: A Victory for QuantWave  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecasted by QuantWave, resulting in a profit margin of 25.34%....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target Forecast with a Profit of 17.34%  ~1 min.

On January 23, 2025, QuantWave, the automated forecasting platform, issued a short forecast signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at 692.73 $....

REGNApril 8, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target with 20% Profit: QuantWave Analysis  ~1 min.

In a recent success for QuantWave's forecasting platform, the stock of REGENERON PHARMACEUTICALS, INC. has hit its price target with a 20% profit margin....

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....